SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001072613-21-000379
Filing Date
2021-04-23
Accepted
2021-04-23 08:46:28
Documents
1
Group Members
ANTHONY A. FLORENCE, JR.FOREST BASKETTJOSHUA MAKOWERMOHAMAD H. MAKHZOUMINEA 15 GP, LLCNEA PARTNERS 15, L.P.PETER W. SONSINISCOTT D. SANDELL

Document Format Files

Seq Description Document Type Size
1 NEW ENTERPRISE ASSOCIATES 15, L.P. / RENEO PHARMACEUTICALS, INC. -- SCHEDULE 13D nea15-reneo_18489.htm SC 13D 358741
  Complete submission text file 0001072613-21-000379.txt   360485
Mailing Address 1954 GREENSPRING DRIVE, SUITE 600 TIMONIUM MD 21093
Business Address 1954 GREENSPRING DRIVE, SUITE 600 TIMONIUM MD 21093 410-842-4000
New Enterprise Associates 15, L.P. (Filed by) CIK: 0001629794 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address P.O. BOX 675614 RANCHO SANTA FE CA 92067
Business Address P.O. BOX 675614 RANCHO SANTA FE CA 92067 619-733-3852
Reneo Pharmaceuticals, Inc. (Subject) CIK: 0001637715 (see all company filings)

IRS No.: 472309515 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-92480 | Film No.: 21846805
SIC: 2834 Pharmaceutical Preparations